$AXON

Brooks Cameron sold $621K of AXON

Brooks Cameron (CHIEF REVENUE OFFICER) sold 1,242 shares of AXON ENTERPRISE, INC. (AXON) at $500.00 ($0.62M total) on 2026-06-04 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Brooks Cameron
Published Jun 8, 2026, 8:56 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 8, 2026, 9:00 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$AXON
Neutral
high confidence
Mentioned
$AXON
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AXONNeutralLow
01

Why it matters

The disclosure updates the record of insider activity but does not, by itself, change AXON’s operating outlook or provide new company fundamentals.

02

Market read

Traders may note the insider sale for sentiment/positioning, but the 10b5-1 structure reduces interpretive weight.

03

What to watch

The article provides only the sale details; it does not indicate whether other insiders bought, whether the plan size is increasing, or whether there were concurrent corporate catalysts.

Relevance 4/10Novelty 2/10Timing: Filed June 8, covering a sale executed June 4.

Background

This is an SEC Form 4 insider transaction disclosure from AXON, reported via SEC EDGAR.

Company-level read

Ticker impact

$AXONNeutralHigh confidence
Context

Brooks Cameron (Chief Revenue Officer) filed an open-market sale of 1,242 AXON shares at $500/share under a 10b5-1 plan.

Expected impact

Likely minimal; any reaction should be muted unless accompanied by other company-specific catalysts.

Evidence & confidence

The filing is a scheduled open-market sale under a pre-arranged 10b5-1 plan, with no accompanying operational or guidance change disclosed.

Market effects

No direct sector read-through; this is an individual insider transaction without disclosed business developments.

None indicated.

None indicated.

Counterpoint

Even with 10b5-1, repeated insider selling can coincide with internal caution; traders may watch for clustering of sales around specific windows.

Key entities

  • AXON ENTERPRISE, INC.

    Company whose shares were sold by an insider under a 10b5-1 plan.

  • Brooks Cameron

    Chief Revenue Officer who sold 1,242 shares in an open-market transaction.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AXONHighAI 9/10

Axon’s (AXON) Dilution Fears Look Overstated

Axon Enterprise (AXON) stock fell after announcing a $1B convertible-note offering, but analysts argue dilution fears are overstated. The notes carry 0% interest, convert at $652.06, and are hedged to $1,049.94. Q2 revenue rose 35% to $904M, marking 10 straight quarters of over 30% growth. Management raised full-year revenue growth outlook to 32-34%. AXON has a Strong Buy consensus rating, with an average price target of $719.55.

$AXONHighAI 8/10

Why Did Axon Stock Fall Ten Percent On A Convertible That Pays No Interest?

Axon Enterprise (AXON) shares dropped 9.8% after announcing a $1.0 billion convertible note offering with a 0% coupon. The market interpreted this as a sign of cash flow challenges despite strong revenue growth (34.6% YoY). The company cited inventory investments and rising component costs. AXON's stock is now 43% below its 52-week high, trading at 11x trailing revenue with shrinking margins.

$AXONHighAI 9/10

Axon Q2FY26 Results: Revenue rises 35% to $904 million, guidance raised

Axon Enterprise reported Q2FY26 revenue of $904M, up 35% YoY, and raised full-year guidance to 32-34% growth. Software & services revenue rose 36% to $398M, while connected devices revenue grew 35% to $507M. Platform solutions revenue surged 123% to $150M. The company plans a $1B convertible note offering due 2031, with net proceeds for general corporate purposes and capped call transactions. Shares were up 0.50% in premarket trading.

$AXONHighAI 8/10

Full Transcript: Axon Enterprise Q2 2026 Earnings Call - (AXON)

Axon Enterprise (AXON) reported a record Q2 2026 with 39% growth, driven by demand for Dedrone, Taser 10, and Axon Body 4. The company raised its full-year revenue guidance to 32-34% growth, citing strong bookings and market expansion. Management highlighted investments in AI and public safety technologies, emphasizing trust and data privacy.

$AXONMedAI 8/10

Axon Rebounded 6% Wednesday. Here’s What Could Drive the Stock Through 2026

Axon Enterprise's stock rebounded 6% to $468 on Wednesday after a 10% drop following a $1 billion convertible notes offering. The company expects 32-34% revenue growth in 2026, with strong Q4 growth anticipated. Analysts maintain bullish targets, citing Axon's faster expansion compared to competitors like Motorola Solutions. The stock has an implied upside of 56% based on a valuation model target of $706.